Play your part in the development of innovative cancer medicines and treatments, bringing the very best to patients at unprecedented speed.
In collaboration with Ellipses Pharma, we’re recruiting for a Senior Scientific Liaison looking for their next challenge.
Ellipses Pharma is an international drug development company, focused exclusively on the development of innovative cancer medicines and treatments. Ellipses utilises the expertise of the world’s largest cancer-focused key opinion leader group to oversee a pipeline of high quality clinical oncology opportunities and to make a difference in the speed and scale at which cancer treatments are developed.
The Scientific Affairs Group
The role will work with Ellipses Pharma’s Scientific Affairs Group (SAG), whose primary focus is to ensure that the patient sits at the forefront of the company’s development process and that the best science underpins decision-making processes. The Scientific Affairs Group is the company’s largest oncology-focused panel of Key Opinion Leaders (KOLs) who provide high-quality, independent and unbiased expertise.
These leaders come from either the forefront of academic research or are practicing clinicians. The Scientific Affairs group is used to validate the science and its clinical application, provide independent clinical consensus to the trial design and source potential development assets. Their insights enable the company to design more effective and efficient clinical trials that utilise novel trial techniques and target highly specific patient populations. The group are part of the whole journey – from selection and trial design, to development and positioning – and have the flexibility to advise on a number of opportunities at once, accelerating the development of potential new treatments for patients worldwide.
The role on offer
Working with a dedicated network of oncology KOLs across the world, you will engage with, expand and manage this network to fulfil the Scientific Affairs Group’s objectives.
Key responsibilities will be the ongoing management of the Scientific Affairs Group and the implementation of the company’s KOL strategy. A key activity will be coordinating the identification, recruitment and onboarding of KOLs into the SAG community and facilitating the SAG on all due diligence projects. The individual will also seek to engage the SAG, and utilise their expertise to inform clinical trial design, as a means of accessing emerging scientific data and treatment protocols.
What you’ll need
- An advanced degree (PharmD, MD or PhD) in a relevant scientific discipline, or an undergraduate degree in a relevant discipline with significant demonstrable experience.
- Sufficient scientific expertise to understand the oncology therapy area in terms of emerging scientific trends, drug development, market demands and patient needs.
- Low ego with strong EQ skills – able to network and interact with very senior global oncologists and endear them to the Ellipses mission.
What you’ll get in return
The role creates a great opportunity for your professional development and comes with a top flight compensation and benefits package, including:
- Excellent salary dependent on experience
- Share options
- Fantastic bonus
- Pension and healthcare
- Health assessments and much more